Pulmonary embolism in children

Area of Science:

• Pediatric Medicine
• Cardiology
• Hematology

Background:

• Pulmonary embolism (PE) is uncommon in children, with a bimodal distribution in neonates and adolescents.
• Predisposing factors include central venous lines, infection, and congenital heart disease.
• Clinical signs are often non-specific or masked by other conditions.

Purpose of the Study:

• To review the current understanding of pediatric pulmonary embolism.
• To highlight differences in etiology, presentation, diagnosis, and treatment compared to adults.
• To identify areas requiring further research in pediatric PE.

Main Methods:

• Review of existing literature and adult guidelines for diagnostic and treatment recommendations.
• Discussion of diagnostic modalities including ventilation/perfusion scintigraphy, CTPA, and MRPA.
• Overview of initial and extended anticoagulant therapies (UFH, LMWH, VKAs).

Main Results:

• PE in children is associated with significant risk factors and non-specific symptoms.
• Diagnostic approaches often adapt adult recommendations, with V/Q scans, CTPA, and MRPA playing roles.
• Treatment involves heparinoids and vitamin K antagonists, with extrapolated duration data from adult studies.
• Mortality is around 10%, often linked to underlying conditions; recurrence data is lacking.

Conclusions:

• Pediatric PE requires tailored diagnostic and treatment strategies due to unique factors.
• Current recommendations are largely based on adult data, highlighting a need for pediatric-specific research.
• Further investigation is crucial to validate and refine management guidelines for children.